Important Announcement


ChemIDplus is moving to PubChem in December 2022.
Please see the NLM Technical Bulletin article for more information.

Skip Navigation
ChemIDplus LiteBrowseAdvanced

Substance Name: Belantamab mafodotin [USAN]
RN: 2050232-20-5


  • A novel anti-BCMA antibody conjugated to microtubule-disrupting agent monomethyl auristatin F.

Molecular Formula

  • C6484-H10008-N1728-O2030-S44.(C49-H66-N6-O11)4

Classification Code

  • Treatment of Multiple Myeloma
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Belantamab mafodotin [USAN]


  • Belantamab mafodotin
  • GSK 2857916
  • GSK 2857916 [WHO-DD]
  • GSK-2857916
  • GSK2857916
  • Immunoglobulin G1, anti-(tumor necrosis factor receptor superfamily protein tnfrsf17),(humanized monoclonal GSK2857914 gamma1-chain), disulfide with humanized monoclonal GSK2857914 kappa-chain, dimer, tetrathioether with N-(6-(3-mercapto-2,5-dioxo-1-
  • Immunoglobulin G1-kappa, anti-(homo sapiens tumor necrosis factor receptor superfamily member 17 (b-cell maturation protein, antigen cd269))humanized monoclonal antibody conjugated to auristatin fgamma1 heavy chain (1-451) (humanized vh (homo sapiens I
  • WHO 10754

Registry Numbers

CAS Registry Number

  • 2050232-20-5


  • DB1041CXDG

System Generated Number

  • 2050232205